BACKGROUND: The decline in asbestos use in the United States may impact mesothelioma incidence. OBJECTIVE: This report provides national and state-specific estimates of mesothelioma incidence in the United States using cancer surveillance data for the entire US population. METHODS: Data from the National Program for Cancer Registries and the Surveillance, Epidemiology, and End Results program were used to calculate incidence rates and annual percent change. RESULTS: During 2003-2008, an average of 1.05 mesothelioma cases per 100 000 persons were diagnosed annually in the United States; the number of cases diagnosed each year remained level, whereas rates decreased among men and were stable among women. CONCLUSION: US population-based cancer registry data can be used to determine the burden of mesothelioma and track its decline. Even 30 years after peak asbestos use in the United States, 3200 mesothelioma cases are diagnosed annually, showing that the US population is still at risk.
BACKGROUND: The decline in asbestos use in the United States may impact mesothelioma incidence. OBJECTIVE: This report provides national and state-specific estimates of mesothelioma incidence in the United States using cancer surveillance data for the entire US population. METHODS: Data from the National Program for Cancer Registries and the Surveillance, Epidemiology, and End Results program were used to calculate incidence rates and annual percent change. RESULTS: During 2003-2008, an average of 1.05 mesothelioma cases per 100 000 persons were diagnosed annually in the United States; the number of cases diagnosed each year remained level, whereas rates decreased among men and were stable among women. CONCLUSION: US population-based cancer registry data can be used to determine the burden of mesothelioma and track its decline. Even 30 years after peak asbestos use in the United States, 3200 mesothelioma cases are diagnosed annually, showing that the US population is still at risk.
Authors: Carolina Mensi; M Bonzini; Maria Macchione; Claudia Sieno; L Riboldi; Angela C Pesatori Journal: Med Lav Date: 2011 Sep-Oct Impact factor: 1.275
Authors: Alison Reid; Peter Franklin; Nola Olsen; Jan Sleith; Latha Samuel; Patrick Aboagye-Sarfo; Nicholas de Klerk; A W Bill Musk Journal: Am J Ind Med Date: 2012-08-09 Impact factor: 2.214
Authors: Phyllis A Wingo; Patricia M Jamison; Robert A Hiatt; Hannah K Weir; Paul M Gargiullo; Mary Hutton; Nancy C Lee; H Irene Hall Journal: Cancer Causes Control Date: 2003-03 Impact factor: 2.506
Authors: Jill A Ohar; Mitchell Cheung; Jacqueline Talarchek; Suzanne E Howard; Timothy D Howard; Mary Hesdorffer; Hongzhuang Peng; Frank J Rauscher; Joseph R Testa Journal: Cancer Res Date: 2015-12-30 Impact factor: 12.701
Authors: Aaron Scott Mansfield; Anja C Roden; Tobias Peikert; Yuri M Sheinin; Susan M Harrington; Christopher J Krco; Haidong Dong; Eugene D Kwon Journal: J Thorac Oncol Date: 2014-07 Impact factor: 15.609